Instrument Inactif

Autres langues Intermolecular Inc

Actions

US45882D1090

Semi-conducteurs

Autres langues

04/03/21	Intermolecular, Inc. Announces the Relocation of the Silicon Valley Innovation Hub from Menlo Park to San Jose Facilities
16/06/20	Intermolecular, Inc. Announces Breakthrough Four-Element ALD Chalcogenide-based OTS for 3D Memory Arrays
14/11/19	Merck setzt sich nach Versum-Übernahme höhere Ziele - Aktie sinkt
14/11/19	Merck setzt sich nach Versum-Übernahme höhere Ziele
24/09/19	Intermolecular, Inc.(NasdaqGM:IMI) dropped from S&P TMI Index
20/09/19	Intermolecular, Inc. Announces Management Changes
20/09/19	Intermolecular, Inc.(NasdaqGS:IMI) dropped from NASDAQ Composite Index
20/09/19	MERCK Kommanditgesellschaft auf Aktien (DB:MRK) completed the acquisition of Intermolecular, Inc..
20/09/19	Intermolecular, Inc.'s Equity Buyback announced on November 6, 2018, has expired.
11/09/19	Bei Merck geht's jetzt ans 'Früchte ernten' - Positives Signal aus USA
11/09/19	Bei Mercks Problemgeschäft soll es ab 2020 wieder bergauf gehen
08/08/19	Intermolecular, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019
08/08/19	Intermolecular : Reports Second Quarter 2019 Financial Results
08/08/19	Pharma- und Laborgeschäft beflügelt Merck - Aktie an Dax-Spitze
08/08/19	Pharma- und Laborgeschäft beflügelt Merck - Aktie gefragt
01/08/19	Intermolecular to Lead Session on 3D XPoint: Current Implementations and Future Trends at Flash Memory Summit 2019
17/07/19	Intermolecular : Stockholders Approve Merck KGaA, Darmstadt, Germany's Proposed Acquisition of Intermolecular
02/07/19	INTERMOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intermolecular, Inc. - IMI
01/06/19	INTERMOLECULAR INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intermolecular, Inc. - IMI
16/05/19	WeissLaw LLP : Investigates Intermolecular, Inc. Acquisition
14/05/19	Intermolecular, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019
14/05/19	Intermolecular : Reports First Quarter 2019 Financial Results
06/05/19	Intermolecular : to be acquired by Merck KGaA, Darmstadt, Germany for $1.20 per share in an all cash transaction
06/05/19	MERCK Kommanditgesellschaft auf Aktien (DB:MRK) signed a definitive agreement to acquire Intermolecular, Inc. for $61.9 million.
24/04/19	Intermolecular : Sets Fiscal First Quarter 2019 Earnings Call for Tuesday, May 14, 2019 at 5 p.m. ET